SS

(redirected from Sjogren syndrome)
Also found in: Dictionary, Thesaurus, Medical, Encyclopedia.
Related to Sjogren syndrome: systemic lupus erythematosus, Scleroderma, Lupus

SS

An abbreviation used in the portion of an Affidavit, Pleading, or record known as the statement of venue.

The abbreviation is read as "to wit" and is intended to be a contraction of the Latin term scilicet.

References in periodicals archive ?
Axonal polyneuropathies were the commonest manifestations of PNS involvement found in 50% of Sjogren syndrome cases in one study20.
Fortunately, researchers are uncovering promising new therapies, such as the drug belimumab, which modulates the excessive immune response that underlies Sjogren syndrome. Also, several integrative interventions such as omega-3 fatty acids, maqui-berry extract, and white peony- extract have been shown to improve symptoms and ease inflammation and autoimmunity.
She was finally diagnosed as Sjogren syndrome with lymphocytic bronchiolitis and pulmonary amyloidosis.
Mariette, "B cells in the pathogenesis of primary Sjogren syndrome," Nature Reviews Rheumatology, vol.
The complaints of xerostomia along with the parotiditis were suggestive of Sjogren syndrome. Anti-Ro (SSA) and anti-La (SSB) antibodies were repeatedly negative, as were rheumatoid factor and antinuclear antibodies (ANA).
Hou, and Xiao W.-G., "Clinical observation on effect of total glucosides of paeony in treating patients with nonsystemic involved sjogren syndrome," CJITWM, vol.
Anti-Ro52 antibodies were described for the first time in 1988 in patients with Sjogren Syndrome [5].
Characteristic of hepatic lesion in primary sjogren syndrome (52 cases reports).
Hypokalaemic quadriparesis in Sjogren syndrome. Indian Journal of Nephrology 2011;21(3):191-3.
Comparison of the AmericanEuropean Consensus Group Sjogren syndrome classification criteria to newly proposed American College of Reumatology criteria in large, carefully characterized sicca cohort.
Painful salivary swellingin patients with Sjogren syndrome presents the clinician with a difficult-to-manage condition, and treatment options are limited.